Advertisement
Singapore markets closed

  • Straits Times Index

    3,290.70
    +24.75 (+0.76%)
     

  • Nikkei

    38,229.11
    +155.13 (+0.41%)
     

  • Hang Seng

    18,963.68
    +425.87 (+2.30%)
     

  • FTSE 100

    8,445.30
    +63.95 (+0.76%)
     

  • Bitcoin USD

    63,079.43
    +2,024.40 (+3.32%)
     

  • CMC Crypto 200

    1,303.61
    -54.40 (-4.01%)
     

  • S&P 500

    5,214.08
    +26.41 (+0.51%)
     

  • Dow

    39,387.76
    +331.36 (+0.85%)
     

  • Nasdaq

    16,346.26
    +43.46 (+0.27%)
     

  • Gold

    2,378.90
    +38.60 (+1.65%)
     

  • Crude Oil

    79.76
    +0.50 (+0.63%)
     

  • 10-Yr Bond

    4.4490
    -0.0430 (-0.96%)
     

  • FTSE Bursa Malaysia

    1,600.67
    -0.55 (-0.03%)
     

  • Jakarta Composite Index

    7,088.79
    -34.81 (-0.49%)
     

  • PSE Index

    6,511.93
    -30.53 (-0.47%)
     

QT Vascular To Establish Drug Coating Development Centre In Singapore

Shares Investment

QT Vascular has announced the establishment of its drug coating development centre in Singapore, with the support of the Singapore Economic Development Board.

The centre will help to boost the group’s research and development efforts in its Chocolate Touch™ drug-coated angioplasty balloon program.

The group is also applying for CE marking approval with respect to the Chocolate® Touch, its advanced drug-coated peripheral balloon.

Drug-coated balloons (DCB) are creating a significant new market space and has been estimated to be worth US$100 million in 2015 and $600 million in 2018 in the American market.



More From Shares Investment: